文献速递类风湿关节炎系统性红斑狼疮其他结缔组织病

整合转录组与表观基因组分析揭示系统性自身免疫病中保守的分子亚型

Integrated transcriptomic and epigenomic profiling reveals conserved molecular subtypes across systemic autoimmune diseases.
PubMed 文献 · Ann Rheum Dis · 2026-05-31

该研究对262例未治疗的中国汉族RA、SLE和pSS患者进行多组学分析,发现两种跨疾病保守分子亚型:巨核细胞富集型和B细胞富集型。巨核细胞富集型与更高血小板计数、更高疾病活动度和更广泛器官受累相关,表观遗传分析揭示了亚型特异的染色质可及性和超级增强子景观。

要点

  • RA、SLE和pSS存在两种跨疾病保守分子亚型:巨核细胞富集型和B细胞富集型。
  • 巨核细胞富集型与更高血小板计数、更高疾病活动度及更广泛器官受累相关。
  • 亚型特异的超级增强子关联巨核细胞基因(如ZFP36L1、RAD51B)和B细胞基因(如MAF、PRDM1)。

核心结论

  • 整合多组学分析定义了RA、SLE和pSS中两种保守的分子亚型,具有不同的细胞和调控程序。
  • 这种跨疾病分类可能有助于精准分层和开发谱系靶向治疗。

研究设计与样本

  • 研究纳入262例未治疗的中国汉族患者(RA:n=109;SLE:n=69;pSS:n=84),女性占83.2%,分为发现队列(n=119)和验证队列(n=143)。
  • 采用批量RNA测序定义分子亚型,并关联临床表型。
  • 通过ATAC-seq和CUT&Tag绘制染色质可及性和超级增强子景观,并进行单细胞RNA测序以描绘亚型特异性细胞组成。

主要发现

  • 整合分析揭示了两种稳健且可重复的分子亚型:巨核细胞富集型和B细胞富集型,在三种疾病和两个队列中一致。
  • 巨核细胞富集型与更高血小板计数、更高疾病活动度和更广泛器官受累相关。
  • 表观基因组分析发现亚型特异的染色质可及性和调控架构,巨核细胞富集型中巨核细胞相关基因(如ZFP36L1和RAD51B)与活跃超级增强子关联,B细胞富集型中B细胞相关基因(如MAF和PRDM1)关联。
  • 单细胞RNA测序证实相应亚型中产血小板巨核细胞扩增和B细胞活化特征增强。

临床怎么用

  • 跨疾病分子亚型可能为系统性自身免疫病的精准分层提供依据。
  • 亚型特异的调控程序可能指导谱系靶向疗法的开发。

局限性

  • 需要进一步的多中心验证。
  • 分子亚型背后的表观遗传机制有待深入研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and primary Sjögren's syndrome (pSS) frequently share overlapping clinical features, yet exhibit substantial intradisease heterogeneity in organ involvement and severity. This study aimed to define conserved molecular subtypes across these systemic autoimmune diseases (SADs) and delineate their transcriptional and epigenetic underpinnings. METHODS: We profiled 262 treatment-naïve Chinese Han patients (RA: n = 109; SLE: n = 69; pSS: n = 84), predominantly female (83.2%), who were divided into discovery (n = 119) and validation (n = 143) cohorts. Bulk RNA sequencing defined molecular subtypes, which were correlated with clinical phenotypes. Chromatin accessibility and super-enhancer landscapes were mapped by Assay for Transposase-Accessible Chromatin with high-throughput sequencing and cleavage under targets and tagmentation, and single-cell RNA sequencing (scRNA-seq) was performed to delineate subtype-specific cellular compositions. RESULTS: Integrative analyses uncovered 2 robust and reproducible molecular subtypes, megakaryocyte-enriched and B-cell-enriched, which were consistent across all 3 SADs and both cohorts. The megakaryocyte-enriched subtype was associated with higher platelet counts, greater disease activity, and broader organ involvement. Epigenomic profiling identified distinct chromatin accessibility and regulatory architectures, with megakaryocyte-associated genes (eg, ZFP36L1 and RAD51B) linked to active superenhancers in the megakaryocyte-enriched subtype, and B-cell-associated genes (eg, MAF and PRDM1) in the B-cell-enriched subtype. scRNA-seq confirmed expansion of platelet-producing megakaryocytes and enhanced B-cell-activation signatures in their respective subtypes. CONCLUSIONS: Integrative multiomics profiling defines 2 conserved molecular subtypes across RA, SLE, and pSS with distinct cellular and regulatory programmes. This cross-disease taxonomy may inform precision stratification and the development of lineage-targeted therapies in SADs. Further multicentre validation and investigation of the epigenetic mechanisms underlying molecular subtypes are warranted.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Fan Y, Su M, Yu L, et al. Integrated transcriptomic and epigenomic profiling reveals conserved molecular subtypes across systemic autoimmune diseases. Ann Rheum Dis. 2026. PMID: 42218077. doi:10.1016/j.ard.2026.05.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。